Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Inhaled Steroids for Radiation Pneumonitis in NSCLC
NCT03803787Phase 2Recruiting
- Start
- Sep 2018
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in radiation pneumonitis (RP). Started Sep 2018; status: recruiting.
02
Drugs
budesonide
03
Conditions
radiation pneumonitis (RP)
Beyond the preview
Go deeper on NCT03803787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03803787.